NO20100775L - Fremgangsmate for okning av utbyttet av et inerferon alfa-preparat - Google Patents

Fremgangsmate for okning av utbyttet av et inerferon alfa-preparat

Info

Publication number
NO20100775L
NO20100775L NO20100775A NO20100775A NO20100775L NO 20100775 L NO20100775 L NO 20100775L NO 20100775 A NO20100775 A NO 20100775A NO 20100775 A NO20100775 A NO 20100775A NO 20100775 L NO20100775 L NO 20100775L
Authority
NO
Norway
Prior art keywords
yield
increasing
inerferon
interferon alfa
alpha preparation
Prior art date
Application number
NO20100775A
Other languages
English (en)
Other versions
NO331699B1 (no
Inventor
Susan Cannon-Carlson
Andres Frei
Seoju Lee
Roland Mengisen
Marcio Voloch
David C Wylie
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Publication of NO20100775L publication Critical patent/NO20100775L/no
Application filed by Schering Corp filed Critical Schering Corp
Publication of NO331699B1 publication Critical patent/NO331699B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/56—IFN-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

Foreliggende oppfinnelse tilveiebringer en fremgangsmåte for økning av utbyttet at et interferon alfa-preparat, som omfatter omdannelse av en pyruvatsupplementisoform av interferon alfa til interferon alfa, hvor supplementisoformen eksponeres for sinkløsninger som eventuelt omfatter en antioksidant.
NO20100775A 1998-11-12 2010-05-27 Fremgangsmate for okning av utbyttet av et inerferon alfa-preparat NO331699B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US19054298A 1998-11-12 1998-11-12

Publications (2)

Publication Number Publication Date
NO20100775L true NO20100775L (no) 2001-05-11
NO331699B1 NO331699B1 (no) 2012-02-27

Family

ID=22701766

Family Applications (2)

Application Number Title Priority Date Filing Date
NO20012327A NO329483B1 (no) 1998-11-12 2001-05-11 Fremgangsmate for okning av utbyttet av et interferon alfa-preparat.
NO20100775A NO331699B1 (no) 1998-11-12 2010-05-27 Fremgangsmate for okning av utbyttet av et inerferon alfa-preparat

Family Applications Before (1)

Application Number Title Priority Date Filing Date
NO20012327A NO329483B1 (no) 1998-11-12 2001-05-11 Fremgangsmate for okning av utbyttet av et interferon alfa-preparat.

Country Status (27)

Country Link
EP (2) EP1894944B1 (no)
JP (3) JP4468585B2 (no)
KR (1) KR100922454B1 (no)
CN (2) CN101255188A (no)
AR (1) AR023906A1 (no)
AT (2) ATE476445T1 (no)
AU (1) AU766309B2 (no)
BR (1) BR9915257A (no)
CA (1) CA2348739C (no)
CY (2) CY1110444T1 (no)
CZ (2) CZ303110B6 (no)
DE (2) DE69942655D1 (no)
DK (2) DK1894944T3 (no)
ES (2) ES2315019T3 (no)
HK (2) HK1112746A1 (no)
HU (1) HU228265B1 (no)
ID (1) ID28552A (no)
IL (2) IL142546A0 (no)
NO (2) NO329483B1 (no)
NZ (1) NZ511074A (no)
PL (2) PL200274B1 (no)
PT (2) PT1894944E (no)
SI (2) SI1129111T1 (no)
SK (2) SK287564B6 (no)
TW (1) TW577894B (no)
WO (1) WO2000029440A1 (no)
ZA (1) ZA200103010B (no)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU228265B1 (en) * 1998-11-12 2013-02-28 Merck Sharp & Dohme Methods of conversion of interferon isoforms and products thereof
WO2010075159A1 (en) 2008-12-23 2010-07-01 Schering Corporation Purification of recombinantly produced interferon
WO2021212220A1 (en) * 2020-04-20 2021-10-28 Altum Pharmaceuticals Inc. Recombinant interferon

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3165463D1 (en) 1980-01-08 1984-09-20 Biogen Nv Dna sequences, recombinant dna molecules and processes for producing human interferon-alpha like polypeptides
US4530901A (en) 1980-01-08 1985-07-23 Biogen N.V. Recombinant DNA molecules and their use in producing human interferon-like polypeptides
US4315852A (en) 1980-11-26 1982-02-16 Schering Corporation Extraction of interferon from bacteria
US4364863A (en) * 1980-12-29 1982-12-21 Schering Corporation Extraction of interferon from bacteria
EP0082481B2 (en) 1981-12-23 1990-09-12 Schering Corporation Stabilised alpha-interferon formulations and their preparation
DE3515336C2 (de) * 1985-04-27 1994-01-20 Boehringer Ingelheim Int Verfahren zur Herstellung und Reinigung von â-Interferon
US4847079A (en) 1985-07-29 1989-07-11 Schering Corporation Biologically stable interferon compositions comprising thimerosal
US4732683A (en) 1986-12-02 1988-03-22 Biospectrum, Inc. Purification method for alpha interferon
US4765903A (en) 1987-10-06 1988-08-23 Interferon Sciences, Inc. Purification of monomeric interferon
US5272135A (en) 1991-03-01 1993-12-21 Chiron Ophthalmics, Inc. Method for the stabilization of methionine-containing polypeptides
AU648214B2 (en) * 1991-12-31 1994-04-14 Lucky Limited Recombinant gene coding for human alpha interferon and expression vector thereof, etc.
DE69522492T2 (de) * 1994-04-09 2002-05-23 Hoffmann La Roche Verfahren zur Herstellung von Alpha-Interferon
US5766582A (en) 1994-10-11 1998-06-16 Schering Corporation Stable, aqueous alfa interferon solution formulations
HU228265B1 (en) * 1998-11-12 2013-02-28 Merck Sharp & Dohme Methods of conversion of interferon isoforms and products thereof

Also Published As

Publication number Publication date
CY1110444T1 (el) 2015-04-29
CN1326465A (zh) 2001-12-12
KR100922454B1 (ko) 2009-10-21
NZ511074A (en) 2003-10-31
IL142546A (en) 2013-07-31
TW577894B (en) 2004-03-01
CN101255188A (zh) 2008-09-03
DE69939657D1 (de) 2008-11-13
CZ20011303A3 (cs) 2001-08-15
CN100390197C (zh) 2008-05-28
EP1129111A1 (en) 2001-09-05
WO2000029440A1 (en) 2000-05-25
AU6387099A (en) 2000-06-05
EP1129111B1 (en) 2008-10-01
JP4468585B2 (ja) 2010-05-26
ATE476445T1 (de) 2010-08-15
BR9915257A (pt) 2001-08-07
ZA200103010B (en) 2002-07-11
SK287564B6 (sk) 2011-02-04
HU228265B1 (en) 2013-02-28
ES2348104T3 (es) 2010-11-30
CY1110794T1 (el) 2015-06-10
ES2315019T3 (es) 2009-03-16
PL201341B1 (pl) 2009-04-30
AR023906A1 (es) 2002-09-04
SK287372B6 (sk) 2010-08-09
PL348162A1 (en) 2002-05-06
NO329483B1 (no) 2010-10-25
KR20010080336A (ko) 2001-08-22
JP2010209117A (ja) 2010-09-24
CA2348739C (en) 2010-05-11
PT1129111E (pt) 2008-12-22
NO331699B1 (no) 2012-02-27
EP1894944A1 (en) 2008-03-05
PL200274B1 (pl) 2008-12-31
HK1112746A1 (en) 2008-09-12
DK1129111T3 (da) 2009-01-05
CZ303110B6 (cs) 2012-04-04
DK1894944T3 (da) 2010-10-18
ID28552A (id) 2001-05-31
DE69942655D1 (de) 2010-09-16
JP2002530291A (ja) 2002-09-17
NO20012327L (no) 2001-05-11
ATE409706T1 (de) 2008-10-15
AU766309B2 (en) 2003-10-16
CZ302402B6 (cs) 2011-05-04
NO20012327D0 (no) 2001-05-11
SK6172001A3 (en) 2001-10-08
SI1129111T1 (sl) 2009-06-30
SI1894944T1 (sl) 2010-11-30
CA2348739A1 (en) 2000-05-25
HK1035544A1 (en) 2001-11-30
EP1894944B1 (en) 2010-08-04
IL142546A0 (en) 2002-03-10
HUP0104113A2 (hu) 2002-03-28
JP2006348056A (ja) 2006-12-28
HUP0104113A3 (en) 2004-04-28
PT1894944E (pt) 2010-10-28

Similar Documents

Publication Publication Date Title
AU589686B2 (en) Intermediates for the production of amino and substituted amino phosphinylalkanoyl compositions
BR9910297A (pt) Novos análogos graxos para o tratamento de diabetes
AR001081A1 (es) Un proceso para preparar ciertos aza ciclohexapeptidos y compuestos preparados mediante dicho proceso
DK0915866T3 (da) Forbedret fremgangsmåde til syntese af beskyttende estere af (S)-3,4-dihydroxysmørsyre
TR199902368T2 (xx) S�lfonamid t�revleri.
MX9605206A (es) 1alfa,26-dihidroxi-d-homo-vitamina d3.
EP0262345A3 (en) Pyrroloquinoline quinones as enzyme inhibitors
NO20100775L (no) Fremgangsmate for okning av utbyttet av et inerferon alfa-preparat
ES8706832A1 (es) Un procedimiento para preparar hidantoinas opticamente activas
ES8301241A1 (es) Un procedimiento para la preparacion de nuevos compuestos de mercaptoorganosiloxano.
DK1206452T3 (da) Fremgangsmåde til fremstilling af benzoperhydro-isoindolforbindelser
AU568064B2 (en) 4-acylamino-1-aza-adamantanes
PL331330A1 (en) Method of obtaining derivatives of 3-pyroline-2-carboxylic acid
AU1600495A (en) Novel indane-2-mercaptoacetylamide disulfide derivatives useful as inhibitors of enkephalinase
DE69703115T2 (de) Zwischenprodukte um 2-imidazolin-5onederivate herzustellen.
NO20001404L (no) Nye stereoselektive fremgangsmÕter for fremstilling av gabapentinanaloger
ES541544A0 (es) Un metodo de preparar bestatinas
DK1062223T3 (da) Præparat som indeholder en precursor der kan hydrolyseres af glucocerebrosidase
MY118813A (en) Compounds and method for preparing substituted 4-phenyl-4-cyanocyclohexanoic acids
ID24516A (id) Proses penyalutan elastomer-elastomer silikon
AU3814800A (en) Enantiomers of mercapto lactones and processes for their synthesis
MY126530A (en) Process for the production of r-(+)-6-carboxamido-3-n-methylamino-1,2,3,4-tetrahydrocarbazole
ES8402269A1 (es) Procedimiento para preparar 3-acetamido-2-(5-metoxiindol-3-il)propanoato de metilo.
BR9908511A (pt) Processo para a preparação de um composto, e, composto
AU7919698A (en) Formic acid solution with reduced corrosive effect

Legal Events

Date Code Title Description
CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: MERCK SHARP AND DOHME CORP

Free format text: NEW ADDRESS: 126 EAST LINCOLN AVENUE, US-NJ07065 RAHWAY, US

MM1K Lapsed by not paying the annual fees